Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Email to Daniel Pavlovich and BOD

<< Previous

Bullboard Posts

Next >>

Post by Lontermon Aug 02, 2021 4:25pm

253 Views

Post# 33640384

Email to Daniel Pavlovich and BOD

Taking cue and various posts from this board I emailed the counsel for Spectral questioning the management participation in the bought deal when they should be in a blackout period and also bought attention to the MOC trades with a closing price of .44c in June and July pointing to Bought deal pre-marketing with a pointer that this deal stincks and may need to be investigated by IIROC-

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing